Literature DB >> 7513016

Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells.

O Devergne1, A Marfaing-Koka, T J Schall, M B Leger-Ravet, M Sadick, M Peuchmaur, M C Crevon, K J Kim, T T Schall, T Kim.   

Abstract

To understand the selective accumulation of memory T helper lymphocytes and of macrophages in delayed-type hypersensitivity (DTH) granulomas, we studied the in situ production of RANTES, a chemokine initially characterized on the basis of its in vitro chemotactic properties for each of these cell populations. RANTES gene expression was studied by in situ hybridization in 15 human lymph nodes presenting typical DTH lesions related to either sarcoidosis or tuberculosis. A positive signal was detected in all cases. Labeling was specific for the DTH lesions, as very few if any positive cells were detected in the normal residual lymphoid tissue surrounding them or in reactive lymph nodes involved in a B lymphocyte response. RANTES gene expression was associated with the production of the protein, which was detected by immunochemistry in DTH lymph nodes. The morphological characteristics and distribution of positive cells in in situ hybridization and immunochemical experiments indicated that macrophages and endothelial cells, two cell populations not previously reported to produce RANTES, contributed to its production in DTH reactions. The ability of macrophages and endothelial cells to produce RANTES was confirmed by in vitro studies with alveolar macrophages and umbilical vein endothelial cells. In view of the chemotactic properties of RANTES for a limited range of cell populations, these results suggest that RANTES production in DTH granulomas may play a role in the selective accumulation of macrophages and memory T helper lymphocytes characterizing this type of cell-mediated immune reaction, and that macrophages and endothelial cells are involved in this production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513016      PMCID: PMC2191500          DOI: 10.1084/jem.179.5.1689

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Cytokine patterns of immunologically mediated tissue damage.

Authors:  M Yamamura; X H Wang; J D Ohmen; K Uyemura; T H Rea; B R Bloom; R L Modlin
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

Review 2.  Cytokine regulation of endothelial cell function.

Authors:  A Mantovani; F Bussolino; E Dejana
Journal:  FASEB J       Date:  1992-05       Impact factor: 5.191

3.  Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes.

Authors:  O Devergne; D Emilie; M Peuchmaur; M C Crevon; M F D'Agay; P Galanaud
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

4.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

Review 5.  Biological properties of interleukin 10.

Authors:  M Howard; A O'Garra
Journal:  Immunol Today       Date:  1992-06

6.  Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas.

Authors:  S W Chensue; K S Warmington; A E Berger; D E Tracey
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

7.  Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin.

Authors:  A Tsicopoulos; Q Hamid; V Varney; S Ying; R Moqbel; S R Durham; A B Kay
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

8.  IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells.

Authors:  O Abehsira-Amar; M Gibert; M Joliy; J Thèze; D L Jankovic
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

9.  Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes.

Authors:  P Heeger; G Wolf; C Meyers; M J Sun; S C O'Farrell; A M Krensky; E G Neilson
Journal:  Kidney Int       Date:  1992-01       Impact factor: 10.612

Review 10.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

View more
  35 in total

1.  Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1.

Authors:  M L Rand; J S Warren; M K Mansour; W Newman; D J Ringler
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 2.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.

Authors:  Livija Deban; Carmen Correale; Stefania Vetrano; Alberto Malesci; Silvio Danese
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

Review 4.  Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells.

Authors:  H Moll; U Ritter; S Flohé; K Erb; C Bauer; C Blank
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

5.  Chemokines and the pathogenesis of T cell-dependent immune responses.

Authors:  W W Hancock
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

6.  CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.

Authors:  R S Kornbluth; K Kee; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

7.  Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin.

Authors:  O Fahy; H Porte; S Sénéchal; H Vorng; A R McEuen; M G Buckley; A F Walls; B Wallaert; A B Tonnel; A Tsicopoulos
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 8.  Cells and molecules involved in the development of sarcoid granuloma.

Authors:  C Agostini; U Basso; G Semenzato
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

9.  Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response.

Authors:  Kshipra Singh; Lori A Coburn; Daniel P Barry; Mohammad Asim; Brooks P Scull; Margaret M Allaman; Nuruddeen D Lewis; M Kay Washington; Michael J Rosen; Christopher S Williams; Rupesh Chaturvedi; Keith T Wilson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-23       Impact factor: 4.052

10.  Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells.

Authors:  Christian Weingart; Peter J Nelson; Bernhard K Krämer; Matthias Mack
Journal:  BMC Immunol       Date:  2008-12-10       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.